Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minoxidil foam versus Men's Rogaine in men with androgenetic alopecia
ChiCTR2500103540Phase 3Not yet recruiting
- Sponsor
- China-Japan Friendship Hospital
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of minoxidil in androgenetic alopecia (AGA) (2 arms), sponsored by China-Japan Friendship Hospital. Primary endpoints: Average change of target area hair count and Change in subject self-rated satisfaction. Planned start May 2025; status: not yet recruiting.
02
Drugs
minoxidil
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on ChiCTR2500103540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500103540.